NYSE:SBS

Companhia De Saneamento Basico Do Estado De Sao Paulo - Sabesp Stock News

Utilities > Regulated Water

Buy SBS

*Your capital is at risk

$5.40

-0.130 (-2.35%)

At Close: Jun 03, 2026

Sabesp Q3: Good Result, But Macro Scenario Continues To Leave Me Skeptical

10:08pm, Wednesday, 04'th Dec 2024

Recommend holding Sabesp shares post-3Q24 results due to good trends, but valuation lacks safety margin amid Brazilian economic instability. Net revenues rose 9.6% y/y to $987 million, driven by tarif

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2024 Earnings Call Transcript

02:45pm, Tuesday, 12'th Nov 2024

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q3 2024 Earnings Conference Call November 12, 2024 9:00 AM ET Company Participants Luiz Tiberio - IR Superintendent Carlos

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

07:00am, Monday, 28'th Oct 2024

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual Scienti

4 Stocks to Buy From the Promising Water Supply Industry

11:30am, Tuesday, 24'th Sep 2024

Water utilities, AWK, SBS, AWR and SJW, are likely to benefit from stable demand for water and wastewater services. Capital-intensive utilities are set to gain from interest rate cuts.

Sabesp (SBS) Is a Great Choice for 'Trend' Investors, Here's Why

09:56am, Friday, 20'th Sep 2024

Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shor

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

10:00am, Tuesday, 27'th Aug 2024

New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept

Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

10:00am, Monday, 19'th Aug 2024

New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept

Here's Why Momentum in Sabesp (SBS) Should Keep going

09:50am, Monday, 19'th Aug 2024

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Str

Here's Why Sabesp (SBS) is Poised for a Turnaround After Losing -11.66% in 4 Weeks

11:20am, Thursday, 13'th Jun 2024

Sabesp (SBS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ear

SBS or GWRS: Which Is the Better Value Stock Right Now?

12:40pm, Wednesday, 12'th Jun 2024

Investors interested in stocks from the Utility - Water Supply sector have probably already heard of Sabesp (SBS) and Global Water Resources, Inc. (GWRS). But which of these two stocks presents invest

Should Value Investors Buy Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) Stock?

10:45am, Wednesday, 12'th Jun 2024

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

06:00am, Tuesday, 21'st May 2024

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present late-breaking data during the 2024 Digestive Disease Week® (DDW) meeting from its

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by